Pacific Hospital Supply Co., Ltd (4126.TWO)
TWD 94.5
(1.07%)
TWD 94.5
(1.07%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 673.8 Million TWD | 18.5% |
| 2022 | 568.57 Million TWD | -5.68% |
| 2021 | 602.8 Million TWD | -0.13% |
| 2020 | 603.59 Million TWD | -15.48% |
| 2019 | 501.41 Million TWD | 64.65% |
| 2018 | 397.94 Million TWD | 0.88% |
| 2017 | 416.75 Million TWD | -12.24% |
| 2016 | 472.14 Million TWD | 0.04% |
| 2015 | 458.18 Million TWD | 8.0% |
| 2014 | 453.69 Million TWD | 4.83% |
| 2013 | 432.8 Million TWD | 2.28% |
| 2012 | 422.71 Million TWD | -2.85% |
| 2011 | 434.8 Million TWD | 7.19% |
| 2010 | 416.33 Million TWD | 22.59% |
| 2009 | -167.06 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 161.24 Million TWD | -6.09% |
| 2024 Q1 | 172.05 Million TWD | 34.16% |
| 2023 FY | - TWD | 18.5% |
| 2023 Q4 | 128.27 Million TWD | -33.06% |
| 2023 Q3 | 191.62 Million TWD | 9.97% |
| 2023 Q2 | 174.24 Million TWD | -3.18% |
| 2023 Q1 | 179.96 Million TWD | 8.33% |
| 2022 Q2 | 113.31 Million TWD | 3.01% |
| 2022 Q4 | 166.13 Million TWD | -7.41% |
| 2022 FY | - TWD | -5.68% |
| 2022 Q1 | 110 Million TWD | 21.0% |
| 2022 Q3 | 179.42 Million TWD | 58.34% |
| 2021 Q1 | 152.05 Million TWD | 3.29% |
| 2021 Q3 | 257.26 Million TWD | 150.08% |
| 2021 Q4 | 90.91 Million TWD | -64.66% |
| 2021 FY | - TWD | -0.13% |
| 2021 Q2 | 102.87 Million TWD | -32.34% |
| 2020 Q1 | 128.52 Million TWD | -54.78% |
| 2020 Q4 | 147.2 Million TWD | -2.15% |
| 2020 Q3 | 150.43 Million TWD | -15.36% |
| 2020 FY | - TWD | -15.48% |
| 2020 Q2 | 177.73 Million TWD | 38.29% |
| 2019 Q2 | 159.42 Million TWD | 32.49% |
| 2019 Q4 | 284.2 Million TWD | 88.76% |
| 2019 FY | - TWD | 64.65% |
| 2019 Q1 | 120.32 Million TWD | -5.5% |
| 2019 Q3 | 150.56 Million TWD | -5.56% |
| 2018 FY | - TWD | 0.88% |
| 2018 Q4 | 127.33 Million TWD | 0.68% |
| 2018 Q3 | 126.47 Million TWD | 30.39% |
| 2018 Q2 | 96.99 Million TWD | 16.63% |
| 2018 Q1 | 83.16 Million TWD | -9.73% |
| 2017 Q4 | 92.13 Million TWD | -30.5% |
| 2017 FY | - TWD | -12.24% |
| 2017 Q2 | 110.45 Million TWD | 16.23% |
| 2017 Q1 | 95.02 Million TWD | 6.0% |
| 2017 Q3 | 132.56 Million TWD | 20.02% |
| 2016 Q2 | 143.96 Million TWD | 0.73% |
| 2016 Q3 | 113.62 Million TWD | -21.08% |
| 2016 FY | - TWD | 0.04% |
| 2016 Q4 | 89.64 Million TWD | -21.1% |
| 2016 Q1 | 142.92 Million TWD | -3.95% |
| 2015 Q3 | 157.97 Million TWD | 83.23% |
| 2015 FY | - TWD | 8.0% |
| 2015 Q1 | 96.99 Million TWD | -29.77% |
| 2015 Q4 | 148.8 Million TWD | -5.81% |
| 2015 Q2 | 86.21 Million TWD | -11.11% |
| 2014 Q1 | 113.72 Million TWD | 16.65% |
| 2014 Q3 | 106.79 Million TWD | 12.32% |
| 2014 FY | - TWD | 4.83% |
| 2014 Q4 | 138.1 Million TWD | 29.32% |
| 2014 Q2 | 95.07 Million TWD | -16.39% |
| 2013 Q1 | 120.68 Million TWD | 12.36% |
| 2013 Q3 | 96.09 Million TWD | -18.93% |
| 2013 Q4 | 97.49 Million TWD | 1.45% |
| 2013 FY | - TWD | 2.28% |
| 2013 Q2 | 118.53 Million TWD | -1.78% |
| 2012 FY | - TWD | -2.85% |
| 2012 Q4 | 107.4 Million TWD | -3.21% |
| 2012 Q3 | 110.97 Million TWD | 5.49% |
| 2012 Q2 | 105.19 Million TWD | 4.95% |
| 2012 Q1 | 100.23 Million TWD | 14.23% |
| 2011 Q1 | 110.77 Million TWD | 7.21% |
| 2011 FY | - TWD | 7.19% |
| 2011 Q4 | 87.74 Million TWD | -25.05% |
| 2011 Q3 | 117.07 Million TWD | -2.45% |
| 2011 Q2 | 120 Million TWD | 8.33% |
| 2010 Q1 | 92.61 Million TWD | 0.0% |
| 2010 FY | - TWD | 22.59% |
| 2010 Q2 | 101.89 Million TWD | 10.02% |
| 2010 Q4 | 103.33 Million TWD | -4.8% |
| 2010 Q3 | 108.53 Million TWD | 6.52% |
| 2009 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 1.01 Billion TWD | 33.355% |
| Bioteque Corporation | 736.13 Million TWD | 8.468% |
| Chi Sheng Pharma & Biotech Co., Ltd | 117.55 Million TWD | -473.194% |
| Sunder Biomedical Tech. Co., Ltd. | 76.61 Million TWD | -779.487% |
| BenQ Medical Technology Corporation | 532.15 Million TWD | -26.618% |
| Unicon Optical Co., Ltd. | 377.24 Million TWD | -78.609% |
| Formosa Optical Technology Co.,Ltd. | 1.04 Billion TWD | 35.55% |
| Medeon Biodesign, Inc. | -1.14 Billion TWD | 159.006% |
| Concord Medical Co., Ltd. | 137.47 Million TWD | -390.13% |
| Crystalvue Medical Corporation | 149.73 Million TWD | -350.008% |
| Perfect Medical Industry Co., Ltd. | 115.48 Million TWD | -483.479% |
| ICARES Medicus, Inc. | 165.54 Million TWD | -307.03% |
| Lagis Enterprise Co., Ltd. | 112.36 Million TWD | -499.659% |
| Amed Co., Ltd. | 157.32 Million TWD | -328.283% |